Anthony Hall

Anthony Hall is an accomplished medical professional with extensive experience in leadership roles within the pharmaceutical and biotechnology sectors. Currently serving as the Chief Medical Officer at Sirgartan Therapeutics and Healx, Anthony also co-founded and holds a position on the Board of Trustees and as a Scientific Advisor for Beacon for Rare Diseases. Additionally, Anthony is a member of the Real World Data Working Group at the Faculty of Pharmaceutical Medicine and serves on the Scientific Advisory Board of Duchenne UK. Anthony Hall earned an MB BS in Medicine from the Royal Free Hospital School of Medicine (1986-1991) and a BSc AKC in Physiology & Pharmacology from King's College London (1983-1986).